# Christine E. Horak

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christine-e-horak/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,201 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 45 |
| i10-index | 73 |
| OpenAlex ID | https://openalex.org/A5110480128 |
| Works | 184 |

## Researcher papers

- [Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/nivolumab-versus-chemotherapy-in-patients-with-advanced-melanoma-who-progressed/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Mechanisms of cancer metastasis](https://scholariq.org/topics/mechanisms-of-cancer-metastasis/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.